CSOP Hang Seng Biotech ETF(03174.HK) closed down 0.85%, latest price at HK$3.520

Newtimespace News, as of the close on April 27, CSOP Hang Seng Biotech ETF(03174.HK) finished at HK$3.520, down 0.85%. The ETF opened at HK$3.532, reached a high of HK$3.538, and touched a low of HK$3.512. The latest trading volume was 402,300 units, with a latest turnover of approximately HK$1.4185 million, and assets under management of approximately HK$901 million.

CSOP Hang Seng Biotech ETF(03174.HK) tracks the Hang Seng Biotech Index, which is compiled and published by Hang Seng Indexes Company Limited. The index aims to track the overall performance of the 30 largest biotech companies listed in Hong Kong that are eligible for Stock Connect trading. Its constituent stocks cover four business sub-categories: pharmaceuticals, biotechnology, drug distribution, and medical equipment and supplies, focusing on core biotech areas such as innovative drugs, CXO, and medical devices. The index provides investors with a high-purity tool for concentrated investment in Hong Kong-listed biotech leaders and capturing the development trends of pharmaceutical innovation.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.